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interference. Mutations in the protospacer adjacent motif (PAM) and seed regions block interference but
promote rapid ‘primed’ adaptation. Here, we use multiple spacer sequences to reexamine the PAM and seed
sequence requirements for interference and priming in the Escherichia coli Type I-E CRISPR–Cas system.
Surprisingly, CRISPR interference is far more tolerant of mutations in the seed and the PAM than previously
reported, and this mutational tolerance, as well as priming activity, is highly dependent on spacer sequence.
We identify a large number of functional PAMs that can promote interference, priming or both activities,
depending on the associated spacer sequence. Functional PAMs are preferentially acquired during unprimed
‘naïve’ adaptation, leading to a rapid priming response following infection. Our results provide numerous
insights into the importance of both spacer and target sequences for interference and priming, and reveal that
priming is a major pathway for adaptation during initial infection.
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ABSTRACT
CRISPR–Cas (clustered regularly interspaced short
palindromic repeats-CRISPR associated) systems
allow bacteria to adapt to infection by acquiring
‘spacer’ sequences from invader DNA into genomic
CRISPR loci. Cas proteins use RNAs derived from
these loci to target cognate sequences for destruc-
tion through CRISPR interference. Mutations in the
protospacer adjacent motif (PAM) and seed regions
block interference but promote rapid ‘primed’ adap-
tation. Here, we use multiple spacer sequences to re-
examine the PAM and seed sequence requirements
for interference and priming in the Escherichia coli
Type I-E CRISPR–Cas system. Surprisingly, CRISPR
interference is far more tolerant of mutations in the
seed and the PAM than previously reported, and this
mutational tolerance, as well as priming activity, is
highly dependent on spacer sequence. We identify a
large number of functional PAMs that can promote in-
terference, priming or both activities, depending on
the associated spacer sequence. Functional PAMs
are preferentially acquired during unprimed ‘naı¨ve’
adaptation, leading to a rapid priming response fol-
lowing infection. Our results provide numerous in-
sights into the importance of both spacer and target
sequences for interference and priming, and reveal
that priming is a major pathway for adaptation during
initial infection.
INTRODUCTION
In bacteria and archaea, CRISPR arrays and Cas pro-
teins comprise anRNA-guided immune system that silences
mobile genetic elements including viruses and horizontally
transferredDNA (1,2). CRISPR–Cas immune systems pro-
ceed through three major steps. First, a short segment of in-
vader DNA is inserted as a new spacer following the first
repeat of the CRISPR array, a process called adaptation
(3,4). Second, the CRISPR array is transcribed and pro-
cessed into short CRISPR RNAs (crRNAs), each contain-
ing a different spacer sequence (5,6). Finally, crRNAs guide
Cas effector proteins to DNA or RNA targets containing
protospacers that match the crRNA spacer sequence, and a
Cas endonucleolytic activity cleaves the target leading to its
destruction, a process called CRISPR interference (7,8).
Based on phylogenetic analysis, CRISPR–Cas systems
are clustered into two classes and five basic types (Types I–
V), which are further divided into 16 subtypes (Types I-A
to I-F and I-U, Types II-A to II-C, and Types III-A to III-
D, Types IV and V) (9). Cas1 and Cas2, the only two pro-
teins that are conserved in all CRISPR–Cas systems, form a
stable heterocomplex that is required for spacer acquisition
(9–13). The mechanisms for CRISPR interference vary be-
tween each type, and subtype-specific interference Cas pro-
teins are common (9). Class 1 (Types I, III and IV) sys-
tems utilize large, multi-protein surveillance complexes as
crRNA effectors and in some cases require a separate Cas
endonuclease (14–16), while Class 2 (Types II, V) systems
require only a single protein that acts as both crRNA effec-
tor and Cas endonuclease (17–20) (for a recent review see
(7)).
Escherichia coli K12 contains a Type I-E CRISPR–
Cas system, which utilizes Cas1 and Cas2 for spacer ac-
quisition and the crRNA-effector complex Cascade and
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the signature endonuclease Cas3 for interference (Figure
1A) (10,13,14,21–27). In this system, adaptation can occur
through two different spacer acquisition processes, termed
‘naı¨ve’ and ‘primed’ adaptation (11,28). Naı¨ve adaptation
requires only Cas1 and Cas2 (29), and occurs when a bac-
terium acquires new spacers from mobile genetic elements
that it has not previously encountered. In contrast, primed
adaptation also requires the interference machinery and
acts as a positive feedback loop, in which spacers already
present against a target promote acquisition of new spacers
from the same target (11,28).
Primed adaptation was identified as a mechanism that al-
lows the host to overcome invader escape from the CRISPR
interference pathway (11). During CRISPR interference,
the Cascade crRNA spacer base pairs to the target-strand
of the protospacer, and the non-target strand is displaced
forming an R-loop (Figure 1B) (21). Cas3 is then recruited
by the Cse1 subunit of Cascade and processively degrades
the DNA (25–27). Cascade is thought to initially recognize
targets based on the presence of a correct protospacer adja-
cent motif (PAM) sequence prior to interrogating the ad-
jacent sequence for complementarity to the crRNA, in a
mechanism that is analogous to other Types I and II crRNA
effectors (Figure 1B) (30–33). R-loop formation proceeds
directionally away from the PAM, and the first base pairs
that form during target binding comprise a seed sequence
that nucleates target binding (Figure 1B) (34,35). Due to
their importance in Cascade–dsDNAbinding, spontaneous
mutations in the PAMand seed regions disrupt high-affinity
target binding and can lead to invader escape fromCRISPR
interference (31,36). However, in some cases these muta-
tions promote primed adaptation, which allows the host
to combat this escape by rapidly acquiring new functional
spacers against other regions of the invader DNA (11). In
addition, primed adaptation enables the CRISPR–Cas sys-
tem to rapidly respond to any mobile genetic element with
imperfect sequence homology to an existing spacer, provid-
ing an important strategy for combating closely related fam-
ilies of viruses and plasmids.
A recent high-throughput plasmid loss assay of a ran-
domized PAM and protospacer library indicated that up
to five mutations in the PAM and seed can still pro-
mote primed spacer acquisition (36). If single mutations
within the PAM or seed dramatically decrease the bind-
ing affinity of Cascade, it is unclear how Cascade may rec-
ognize these types of targets in order to promote primed
spacer acquisition. Recent single-molecule FRET studies
of Cascade–DNA binding revealed that Cascade adopts a
non-canonical binding mode when bound to a target with
an incorrect PAMor containing partial complementarity in
the seed, suggesting that priming targets are bound by Cas-
cade, but in an alternative binding mode as compared to
bona fide targets (37).
Genome editing studies using the Type II crRNA effec-
tor endonuclease Cas9 have revealed that targets with PAM
and seed mutations can still be cleaved by Cas9, but that
this mutational tolerance is dependent on the spacer se-
quence of the crRNA (38–42). In contrast, the effects of
spacer sequence on Type I-E interference and priming ac-
tivity have not been studied systematically. Here, we have in-
vestigated the priming efficiency of a large variety of spacer
sequences in E. coliK12 against targets with a single muta-
tion in the seed. Surprisingly, the spacers display extremely
varied activities against seed mutant protospacers for both
priming and direct interference. For many of the spacers
tested, single seed mutations did not block direct inter-
ference or promote priming, suggesting that the level of
priming and seed mismatch tolerance may be dependent
on spacer sequence. To test the importance of spacer se-
quence on PAM or seed mutation tolerance, we have de-
veloped a high-throughput assay that distinguishes between
direct interference and priming activity. Our results reveal
spacer-specific differences in CRISPR activity against both
PAM and seed mutant targets, including several mutations
that completely block CRISPR activity from one spacer but
allow robust CRISPR activity from another. We find that
Type I-E CRISPR–Cas systems can avoid priming against
self sequences based on the presence of a self-signal in the
CRISPR repeat. In addition, PAM authentication for tar-
gets with PAM sequences that promote priming occurs fol-
lowing Cascade binding but prior to Cas3 degradation. In-
triguingly, many of the functional PAMs identified in our
study are preferentially acquired during unprimed ‘naı¨ve’
adaptation, leading to a rapid priming response follow-
ing infection. These findings reveal the importance of both
the spacer and target sequence in CRISPR–Cas activity,
and highlight the sophistication of the adaptive immune re-
sponse in the Type I-E system.
MATERIALS AND METHODS
Bacterial strains
Strains, plasmids and oligonucleotides used in this study
are listed in Supplementary Tables S1–S4. E. coli K12
BW25113 was used as background for all constructed
strains (43,44). Individual gene deletion strains for hns,
cas3, cse1, cas1 were obtained from the Keio collection
(44). The cas3, cse1 or cas1 deletions were moved from
BW25113 cas3::kan, BW25113 cse1::kan or BW25113
cas1::kan into BW25113 hns or E. coli X019 using P1
phage transduction. Kanamycin resistance cassettes were
removed for all strains using pCP20 (45), with the excep-
tion of the cas3::kan cassette in strain X030 (Supplemen-
tary Table S1). The X019 strain, in which spacers 1.2–1.12
and 2.2–2.6 were deleted was created using lambda Red re-
combinase, as previously described (43). DNA fragments
containing kanamycin resistance cassette flanked by FRT
sites with 50-bp homology to CRISPR 1 or CRISPR 2-
adjacent sequences were created using primers XCY302–
303 and XCY304–305, respectively (Supplementary Table
S3).
Plasmid construction
All protospacers used in this study were ligated to
pACYCDuet-1 or pCDF-1b between BgIII and XhoI
or NcoI and NotI sites as indicated (Supplementary
Tables S2 and S3). For recombinant Cascade expres-
sion with different spacer sequences, CRISPRs bear-
ing spacers 1.1, 1.6, 1.9 or 2.1 were generated using
pWUR547 (21) as template with primers indicated in Sup-
plementary Tables S2 and S3 through ‘round-the-horn
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(RTH) cloning (http://openwetware.org/wiki/’Round-the-
horn site-directed mutagenesis). For recombinant Cascade
expression and purification, the N-terminal Streptactin-
tag in Cse2 of pWUR480 (14) plasmid was changed to a
His6-tag using HL005 and HL006 through RTH cloning
to produce pDGS010. For recombinant Cas3 expression
and purification, the cas3 gene was amplified from the E.
coli K12 genome using XCY001 and XCY002 and cloned
into pSV272, encoding an N-terminal His6-MBP (maltose-
binding protein) tag. For the Cas1 and Cas2 expression
plasmid pX288, PCR product of native tac promoter con-
trolled Cas1-Cas2 was cloned using XCY255 and XCY256
in pACYCDuet-1.
For the pACYC-GFP-tac plasmid, a tac promoter (46)
controlled GFP gene was PCR amplified from psfGFP us-
ing XCY413 and XCY417 and cloned into pACYCDuet-
1 (Supplementary Tables S2 and S3). Our preliminary re-
sults indicated that the use of a native tac promoter for
GFP expression slowed E. coli growth, changing the GFP+
and GFP- cells ratio through a non-CRISPR related mech-
anism. To solve this problem, the native tac promoter was
changed to a weaker tac-derived promoter (47). The result-
ing plasmid (pACYC-GFP-pro3) did not increase the dou-
bling time of E. coli compared to E. coli bearing empty
pACYCDuet-1. Competition assays between E. coli X019
bearing either empty pACYCDuet-1 or pACYC-GFP-pro3
further indicated that GFP expression does not affect the
ratio of GFP- and GFP+ cells, as ratios between the two
strains remained constant after 24 h growth without selec-
tion. To decrease the half-life of GFP, the protease-sensitive
SsrA peptide tag AANDENYALAA (48) was added to
the C-terminus of GFP using XCY449 and XCY452 with
pACYC-GFP-pro3 as template through RTH cloning. This
final plasmid is referred to as pACYC-GFP throughout the
text.
CRISPR-like plasmid pRep-Sp8-Rep was created by
cloning a PCR amplicon containing the first two repeats
and one spacer (spacer #8) from E. coli PIM5 (28) into the
PciI site of plasmid pGFP-Kan (36) (Supplementary Ta-
bles S2 and S3 for plasmids and primers). This plasmid then
served as a template to create derivative plasmids pSp8-Rep
(containing the distal repeat) and pRep-Sp8 (containing the
proximal repeat). Plasmids were PCR amplified using Phu-
sion DNA polymerase, 5′ phosphorylated using T4 polynu-
cleotide kinase, end-to-end ligated, and transformed to E.
coli XL1 Blue. pRep-Sp8 then served as a template for a
series of 16 derivative plasmids (Supplementary Table S2),
using primers listed in Supplementary Table S3. Plasmids
sequences were confirmed by Sanger sequencing at GATC
Biotech (Konstanz, Germany).
pACYC-Cas3-C85Venus-Cse1-N155Venus (referred as
pACYC-BiFC in the paper) was created by Gibson Assem-
bly using primers XCY479–XCY486 (Supplementary Ta-
ble S3) (49). Cas3 contains a C-terminal fusion of the C-
terminal Venus fragment and Cse1 contains a C-terminal
fusion of the N-terminal fragment of Venus. The expression
vector was assembled from 4 separate PCR products am-
plified using either pACYC-Cas3-Cse1 or mVenus-pBAD
vector (a gift from Michael Davidson (Addgene plasmid #
54845)) as template.
Plasmid-loss and spacer acquisition experiments
Plasmids were introduced into E. coli BW25113 derived
strains via heat shock and single colonies were used to inoc-
ulate initial cultures. All strains were grown for 24 h (sub-
cultured at 12 h) in 2 ml LB in 15 ml tubes at 37oC with
shaking at 200 rpm. For passaging, 20l of culture was sub-
cultured into 2 ml LB. When indicated, further periods of
incubation were performed at the same conditions. E. coli
cultures were diluted 250 000-fold and 10 l of the final di-
lution was plated on LB plates (1.5% agar) without antibi-
otic. After 6 h, 35–50 colonies on these plates were repli-
cated onto LB plates supplemented with chloramphenicol
to check for plasmid loss. For each sample, 16 colonies on
the no antibiotic plates were picked randomly to analyze
spacer acquisition by colony PCR using Taq DNA poly-
merase. Newly acquired spacers in CRISPR 1 or CRISPR
2 were detected by PCR using primers XCY076–077 or
XCY152–153, respectively (Supplementary Table S3). PCR
products were visualized on 2% agarose gels stained with
SYBR Safe (Thermo Fisher Scientific). All experiments
were performed for three individual cultures. Plasmid loss
and spacer acquisition rates reflect the average of these three
biological replicates, and errors are the standard deviation
between replicates.
Plasmid loss experiments to assess autopriming were per-
formed in E. coli strain PIM5 (28), which is a derivative of
BW25113 hns. Plasmids were transformed into PIM5 by
electroporation, and strains were grown for 48 h in non-
selective liquid media. Plasmid loss was assessed on non-
selective plates by scoring fluorescence of the colony result-
ing from the presence of the GFP plasmid. Non-fluorescent
colonies were analyzed by colony PCR for the integration of
new spacers in CRISPR 1 and 2, and sequenced to confirm
the strand bias that is typical for priming in E. coli strains
with Type I-E CRISPR–Cas systems (11).
Protein expression and purification
Cascade lacking Cse1 (Cse2–Cas6e) was expressed in
BL21(DE3) cells using pDGS010, pWUR404 and the ap-
propriate CRISPR expression plasmid (spacer 1.1: pX238,
spacer 1.6: pX230, spacer 1.9: pX503, spacer 2.1: pX569,
Supplementary Table S2) in 1 l LB media supplemented
with ampicillin, chloramphenicol and streptomycin. Cul-
tures were grown to 0.5 OD600 at 37◦C, and induced
overnight at 16◦C with 0.5 mM IPTG. His6-tagged Cse2–
Cas6e was purified using HisPur Ni-NTA affinity resin
(Thermo Fisher Scientific). The eluent was concentrated to
∼1 ml, then purified by size exclusion chromatograph using
a Superdex 200 column (GE Life Sciences) in a buffer con-
taining 20 mM Tris (pH 7.5), 100 mM NaCl, 5% glycerol
and 1 mM TCEP. Cse1 was expressed in BL21(DE3) using
the EcCse1-pSV272 expression vector, and purified as pre-
viously described (30). Cas3 was expressed in BL21(DE3)
using the Cas3-pSV272 expression vector (Supplementary
Table S2) and purified as described previously with the fol-
lowing modifications (25). During the whole Cas3 purifica-
tion process, 1mMTCEPwas added in all buffers. To main-
tain the activity of Cas3, the purification process was com-
pleted in one day. Briefly, after lysis and affinity purification
using HisPur Ni-NTA resin, His6-MBP-Cas3 was purified
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on a Superdex 200 column. The purified His6-MBP-Cas3
protein was cleaved by tobacco etch virus protease for 3 h
at 4◦C. The cleaved sample was flowed through a Ni-NTA
column, concentrated to 1 ml, and finally purified on a Su-
perdex 200 column.
DNA binding and cleavage assays
All binding assayswere performed in binding buffer: 20mM
Tris (pH 7.5), 100 mMNaCl, and 5% glycerol. All cleavage
assays were performed in reaction buffer: 10 mM HEPES
(pH 7.5), 100 mM KCl, 5% (v/v) glycerol, 2 mM ATP, 100
M CoCl2, and 10 mM MgCl2. Concentrations indicated
for Cascade in Figure 1E, 6A–C, Supplementary Figures
S2A and S7B–D are for the Cse2–Cas6e complex, as Cse1
was held at a constant concentration to ensure complete for-
mation of the Cascade complex (30). Cse2–Cas6e at indi-
cated concentrations and 1000 nMCse1 were pre-incubated
for 20 min at 37◦C to form the Cascade complex. Sam-
ples were cooled on ice for 1 min prior to initiating bind-
ing or cleavage reactions. For Cascade–DNA binding, Cas-
cade was incubated with 2 nM target plasmid, and samples
were incubated at 37◦C for 30 min prior to electrophore-
sis on a 0.8% agarose gel stained with SYBR Safe run at
15 V at 4◦C for 18 h. For Cas3 cleavage, Cascade was incu-
bated with 2 nM target plasmid at 37◦C for 15 min. Cas3
was added at the indicated concentration to initiate plas-
mid digestion. Reactions were incubated at 37◦C for 30 min
and terminated by the addition of 20 mM EDTA. Proteins
were removed by phenol extraction. Reactions were ana-
lyzed by electrophoresis on a 1% agarose gel stained with
SYBR Safe.
Generation of PAM and seed libraries
To avoid sequence bias, initial libraries were constructed in
DH5 byRTH cloning using pACYC-GFP as template (see
Supplementary Table S3 for primers). Primer locations were
designed to avoid complementarity between the overhang-
ing degenerate sequence and the template. However, this li-
brary design did not result in an unbiased library for the
original spacer 1.1 seed library, so an alternative method
was used for spacer 1.1 and 2.1 6MM seed library cre-
ation. A 24-bp protospacer (position 9 to position 32) of
spacer 1.1 (XCY573 and XCY574) or spacer 2.1 (XCY577
and XCY578) (Supplementary Table S3) was ligated into
pACYC-GFP to create pX735 and pX737, and these plas-
mids were used as templates for RTH cloning of the li-
braries. All primers were phosphorylated using polynu-
cleotide kinase prior to PCR. Primers were used to PCR
amplify the pACYC-GFP, pX735 or pX737 backbone and
PCR products were purified. PCR products were ligated
and transformed into E. coli DH5. For each library, over
30,000 transformants were isolated. All colonies were re-
suspended in LB, the bacteria were pelleted, and plasmids
were extracted using a Promega Wizard Plus SV Miniprep
DNA Purification kit. This procedure yielded the five orig-
inal libraries, PAM of spacer 1.1, seed of spacer 1.1, PAM
of spacer 2.1, and two seed libraries of spacer 2.1. All li-
braries were prepared in triplicate from three separate lig-
ations and DH5 transformations. High-throughput plas-
mid loss, priming assays and sequencing were performed for
all three biological replicates.
High-throughput plasmid loss and priming assays
All original libraries were transformed into X019, X019
cse1 andX019cas1 and plated ontoLBplates with chlo-
ramphenicol yielding around 30 000 colonies. All colonies
were resuspended using 1 ml LB. After adjusting the con-
centration of the resuspended bacteria to OD600 of∼5.0, 20
l of the culture was used to inoculate 2 ml LB without an-
tibiotic for five growth cycles, with sub-culturing every 6 or
12 h. Next, 40 l of the each culture was used to inoculate 4
ml LB supplemented with chloramphenicol. These cultures
were grown at 37◦C with shaking at 200 rpm for 12 h and
plasmids were extracted, yielding an additional 12 plasmid
libraries. These 12 plasmid libraries and the four original
plasmid libraries were transformed into X019 and cultured
for two cycles, sub-cultured at 6 or 12 h. The cultures were
diluted 100-fold and analyzed by BDFACSAria III flow cy-
tometer. For each culture, 100 000 GFP+ and GFP- cells
were sorted. The average percentage of GFP-cells for three
biological replicates are reported in Figure 2D, and errors
reflect the standard deviation between the three replicates.
Spacer acquisition was analyzed for the genomic DNA of
the sorted GFP- cells by PCR amplification using XCY076
and XCY077 for CRISPR 1 and XCY152 and XCY153 for
CRISPR 2. PCR products were analyzed on a 2% agarose
gel stained with SYBR Safe, and intensity of PCR bands
was measured using ImageQuant TL (GE Life Sciences).
Spacer acquisition rates were measured as the intensity of
extended CRISPR PCR products relative to the intensity
of total PCR product. The relative intensity of CRISPR
1 and CRISPR 2 were averaged to determine the relative
spacer acquisition for each sample. Spacer acquisition rates
reported in Figure 2E are the average from three separate bi-
ological replicates and error bars reflect standard deviation
between the three replicates.
MiSeq Illumina sequencing
The PAM and seed libraries extracted from DH5, X019,
X019 cse1, and X019 cas1 were amplified by PCR us-
ing Phusion DNA polymerase using a pair of primers con-
taining unique 6-nt barcodes to differentiate between li-
braries and replicates (Supplementary Table S4). The 100–
120 bp PCR fragments were analyzed by 2% agarose gel
electrophoresis and absorbance at 260 nm. Based on the
gel analysis and absorbance reading, equal quantities were
mixed and pooled. The mixed samples were run on a 2%
agarose gel, the band was excised and purified using a
Promega Wizard Gel and PCR Clean-up kit. Samples were
analyzed on anAgilent 2100 Bioanalyzer and a Qubit Fluo-
rometer (Thermo Fisher Scientific) to determine DNA size
and concentration. Samples were prepared for Illumina Se-
quencing using the TruSeqNanoDNASample Preparation
kit (v3) for 1× 150 bp (single-end). To increase the diver-
sity of sequences, samples were spiked with∼30% of a PhiX
Control v3 adapter-ligated library. Samples were sequenced
on an Illumina MiSeq at the Iowa State University DNA
Facility.
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Plasmid libraries were sequenced in three separateMiSeq
runs (Supplementary Table S5). MiSeq run 1 contained the
three replicates each for the PAM and seed libraries for
spacer 2.1. MiSeq run 2 contained three replicates for the
PAM library for spacer 1.1 and three replicates for an in-
complete seed library for spacer 1.1, which had 42 sequences
with fewer than 100 reads in all libraries. Analysis of this li-
brary is included in Supplemental Data File 1, although this
analysis was omitted in the main text. MiSeq run 3 con-
tained three replicates each for the redesigned spacer 1.1
seed library and the spacer 2.1 6MM library.
Analysis of MiSeq data
Sequences fromMiSeq output files were demultiplexed and
sorted into separate files for each library and replicate based
on the presence of specific pairs of barcodes at both ends
of the read using a bash script (Supplementary Table S4).
Reads corresponding to the target (forward reads) and non-
target (reverse reads) strand of the protospacer were sorted
separately. To determine read counts for all possible se-
quences in each library, the resulting files were searched
for the 64 or 128 possible PAM/protospacer sequences for
each PAM or seed library, respectively. An output file was
generated for each replicate of each library containing the
counts for each PAM/protospacer search sequence in the
forward and reverse direction (compiled in Supplemental
Data File 1). Forward read counts for highly depleted se-
quences in the X019 cas1 and X019 library were system-
atically higher than reverse read counts for the same se-
quences. This phenomenon does not appear to be a result of
the demultiplexing strategy, as demultiplexing using alter-
native methods (fastx-multx command from ea-utils pack-
age (50) or sabre (https://github.com/najoshi/sabre)) pro-
duced very similar results. Overall trends in sequence de-
pletion are the same between forward and reverse reads, al-
though the absolute value of counts differs. Therefore, for-
ward and reverse read counts were summed and treated as
total read counts for each sequence. Read counts between
samples were normalized by calculating a scaling factor
based on the sample with the highest number of sequences.
For seed libraries, sequences with anomalously high read
counts (>2-fold greater than the DH5 reference library
following normalization) in the X019 or X019 cas1 were
omitted when calculating the scaling factor. Normalized
read counts from three biological replicates for each library
were averaged and standard deviations were determined. To
determine the relative number of counts for each sequence
in the experimental libraries, average read counts for X019
cse1,X019 cas1, and X019 libraries were divided by the
average read count for the DH5 reference library. Stan-
dard deviations were propagated and are reported as errors
for relative counts in Figures 3B–C, 4A–B, Supplementary
Figures S4 and S6.
Fluorescence microscopy
BiFC experiments were performed in E. coli X030 (Sup-
plementary Table S1) carrying pACYC-BiFC and empty
pCDF-1, pCDF-1b bearing spacer 2.1 AAG target, or
pCDF-1b bearing spacer 2.1 AGA target. Single colonies
were grown at 37◦C in LB containing chloramphenicol (34
ug/ml) until OD600 reached 0.05. Cultures were shifted to
18◦C for 6 h to ensure that plasmid loss of the pCDF-1b
bearing spacer 2.1 AAG target would occur slowly, allow-
ing for fluorescence to be observed. Cells were adjusted to
OD600 0.5 and re-suspended in phosphate buffer (pH 7.2)
and 5 l of the cells were applied to poly-L-lysine covered
microscope slides, and analyzed using a Leica SP5 X MP
confocal/multiphoton microscope system with an inverted
microscope front end, with a 40× oil immersion objective
and an argon laser as the excitation source (514 nm) and
detection at 530–600 nm.
Analysis of naı¨ve PAMs and simulation of adaptation
A data set generated by Yosef et al. was used to analyze the
frequency of PAMs of targets for spacers acquired through
naı¨ve adaptation (29). Spacer sequences and genomic or
plasmid locations were reported in the original paper. PAM
sequences were extracted from the genomic (NCBI Ref-
erence sequence NC 012947.1) or plasmid sequences (re-
ported in (10)) using the BEDtools getfasta tool (51).
In scenario 1, pX288 (pACYC-Cas1–2) and empty
pCDF-1b were co-transformed into the X019 cse1 E. coli
strain. In scenario 2, pX288 and priming plasmid (pCDF-
1b bearing a spacer 2.1 target with an AGA PAM) were
co-transformed into the X019 strain. In scenario 3, pX288
and empty pCDF-1b were co-transformed into the X019
strain. Single colonies were grown to saturation (OD600 of
3.5) for two cycles in LB supplemented with chlorampheni-
col to maintain pX288. The 5′-end of CRISPR 1 was PCR
amplified from genomic DNA isolated from each culture
using XCY076 and XCY077 (Supplementary Table S3) and
visualized on a 2% agarose gel stained with SYBR Safe
to test for spacer acquisition. The relative amount of each
band corresponding to a different number of acquired spac-
ers was determined by densitometry using ImageQuant TL
software. Cultures were performed in triplicate and the av-
erage amount of product is plotted in Figure 7B, with error
bars reflecting the standard deviation between replicates.
RESULTS
Mutations in the seed region do not abolish CRISPR inter-
ference
To date, only a limited number of spacers have been used to
study priming in E. coli, and it is unknown how spacer se-
quence may affect direct interference or priming efficiency
in the presence of PAM or seed mutations. To test a larger
pool of spacers, we investigated the priming efficiency of the
18 endogenous spacers present in the twoCRISPR loci ofE.
coliK12 against targets withmutations at the first seed posi-
tion (Figure 1A and B). For each spacer, we created a target
plasmid containing a 35-bp sequence comprising an AAG
PAM and a 32-bp protospacer with a mismatch at the first
seed position, which has previously been shown to block in-
terference and promote priming (11,31,36) (Figure 1B). We
then tested the rates of plasmid loss and spacer acquisition
for each target plasmid in the CRISPR active strain E. coli
BW25113 hns (28,52–55) after 24 h growth without an-
tibiotic selection. All 18 target plasmids are stable in a cse1
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Figure 1. Seed mutations do not completely block CRISPR interference.
(A) CRISPRs and cas operon from E. coli K12. Genes and stoichiometry
of Cascade proteins are indicated. (B) Construct design for priming targets
for 18 endogenous E. coli K12 spacers. PAM/protospacer sequences were
inserted into pACYCDuet-1. CRISPR 1 spacer 1 and target sequence con-
taining a mismatch at the first position of the seed are shown. (C) Spacers
acquisition and plasmid loss rates for each endogenous spacer against a
target with a mismatch at the first seed position after 24 h growth. Position
1 of the crRNA spacer sequence and the corresponding mismatched nu-
cleotide in the target are labeled for each spacer. Spacers are named based
on their CRISPR and position within the CRISPR (e.g. CRISPR 1 spacer
1 is 1.1, CRISPR 2 spacer 1 is 2.1 etc.). (D) Plasmid loss rates of spacer 1.1
and 1.6 targets with seed position 1 mismatches in E. coli BW25113 hns
andBW25113hnsΔcas1 after 24 h growth. (E) In vitroCascade-mediated
Cas3 degradation of pACYCDuet-1 target plasmids. Cascade (Cse1 at 1
Mand Cse2–Cas6e-crRNA complex at indicated concentration) bearing
spacer 1.1 or 1.6 crRNA and Cas3 concentrations are indicated. The first
base pair of the crRNA spacer and target is labeled for each plasmid tested.
Plasmid DNA is labeled as follows: OC – open circle; L – linear; nSC –
negatively supercoiled. (F) Spacer acquisition and plasmid loss rates in E.
coliBW25113 hnsfor bona fide spacer 1.1 and 1.6 targets after 24 h growth,
colored as in (C).
deletion strain (BW25113 hnscse1), which knocks out
Cascade DNA-binding activity and CRISPR interference,
indicating that any observed plasmid loss in BW25113hns
is the result of CRISPR interference.
Surprisingly, the 18 spacers display extremely varied ac-
tivities for both plasmid loss and spacer acquisition (Fig-
ure 1C). Three spacers (spacers 1.1, 1.8 and 2.4) displayed
higher rates of spacer acquisition than plasmid loss, while
most of the remaining spacers exhibited higher rates of plas-
mid loss than spacers acquired. Several plasmids (targets for
spacers 1.2, 1.6, 1.7, 2.1 and 2.2) were lost in all colonies
tested. For half of the spacers (1.2, 1.5, 1.6, 1.7, 1.10, 2.1,
2.2, 2.3 and 2.6), target plasmid loss appears to be largely
independent of spacer acquisition, as plasmids were lost
in >98% of colonies before even 30% of bacteria had ac-
quired new spacers. Two spacers (1.9 and 1.11) displayed
low CRISPR activity against both mutant and bona fide
targets (AAG PAM and no mutations in protospacer) (Fig-
ure 1C, Supplementary Figure S1A), but this low activity
may be due to defects in Cascade assembly due to high G-
C content (spacer 1.9) or mutations in the repeat (spacer
1.11) (Supplementary Figure S1B and C). Overall, these re-
sults suggest that the majority of endogenous E. coli K12
spacers can direct interference against targets containing a
mutation at the first seed position, in contrast to numer-
ous reports that base pairing at seed position 1 is strictly
required for Cascade-directed target binding and interfer-
ence (11,31,36).
To verify that the observed plasmid loss is based on di-
rect CRISPR interference from the original spacer and not
from newly acquired spacers, we created a cas1 deletion
strain (BW25113 hnsΔcas1), which maintains the inter-
ference pathway but knocks out spacer acquisition activity.
We chose to further analyze mutant targets for two spac-
ers (1.1 and 1.6) that displayed substantially different rates
of plasmid loss in our initial assay (Figure 1C). Plasmid
loss for these targets is similar in the Δhns and ΔhnsΔcas1
strains, confirming that the observed CRISPR interference
is independent of new spacer acquisition and is directed by
the original spacer (Figure 1D).
It is possible that differences in the amounts of individ-
ual crRNAs in the cell may affect the observed variations
in plasmid loss in our in vivo assay. To address this possibil-
ity, we next examined whether the differences in CRISPR
interference observed in vivo for spacer 1.1 and 1.6 mutant
targets could be recapitulated in vitro. To test this, we pu-
rified Cascade bearing a crRNA with either spacer 1.1 or
1.6 and performed Cascade-mediated Cas3 cleavage assays
for bona fide and seed position 1 mutant targets (Figure 1E
and Supplementary Figure S2A). For each target, cleavage
wasmeasured at varied Cascade (5, 50 and 200 nM) or Cas3
(200 and 1000 nM) concentrations (Figure 1E and Supple-
mentary Figure S2A). We observe similar cleavage activity
for both bona fide targets and the spacer 1.6 target with
an rT-dG mismatch, even at low Cascade concentration (5
nM), suggesting that Cascade affinity is not perturbed sub-
stantially for this mutant target (Figure 1E). In contrast,
the spacer 1.1 rC-dA mismatch target plasmid appears to
be completely intact at both 5 and 50 nM Cascade and is
only cleaved at the higher concentration (200 nM) regard-
less of Cas3 concentration, suggesting that Cascade has a
greatly reduced affinity for this target (Figure 1E and Sup-
plementary Figure S2A). Accordingly, in the E. coli X019
strain, in which the cellular concentrations of Cascade bear-
ing spacer 1.1 is increased by deleting all spacers except for
1.1 and 2.1 (Supplementary Figure S2B), CRISPR interfer-
ence against the mutant spacer 1.1 target is increased sub-
stantially in comparison to BW25113hns (Supplementary
Figure S2C). Priming does not increase for the X019 strain
(Supplementary Figure S2D), suggesting that the increased
rate of interference may preclude a concurrent increase in
spacer acquisition. Together, these data indicate that defects
in Cascade binding can inhibit CRISPR interference, as has
been previously proposed (31), but that seed position 1 mu-
tants do not significantly disrupt Cascade binding for all
spacer sequences.
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Previous reports have indicated that single point muta-
tions throughout the seed (positions 1–5, 7 and 8 of the
protospacer) inhibit Cascade-target binding and direct in-
terference (31,36). To determine whether the mismatch tol-
erance we observed at seed position 1 is position-specific,
we tested the effect of single mutations at each position of
the seed region for spacers 1.1 and 1.6 on plasmid loss and
spacer acquisition. For all targets, we observe >90% plas-
mid loss, and several mutant targets were lost in all colonies
tested (Supplementary Figure S2E). Spacer acquisition for
all mutant targets was substantially lower than plasmid loss
(Supplementary Figure S2E), although we observed overall
higher rates of priming for spacer 1.1 targets than for spacer
1.6. Together, these results indicate that single seed muta-
tions are not sufficient to completely block CRISPR inter-
ference for these spacers, and that the efficiency of priming
may be dependent on spacer sequence.
Bona fide targets can promote spacer acquisition through
priming
Based on our initial results, we found that spacer acquisi-
tion could occur for all seed mutations, even those that do
not significantly inhibit direct interference. These results in-
dicate that bona fide protospacersmay also promote primed
spacer acquisition. To test this, we measured the rate of
spacer acquisition of bona fide targets for spacers 1.1 and
1.6 in E. coli BW25113 hns, which can acquire spacers
through naı¨ve or primed acquisition, and E. coli BW25113
hnsΔcse1, which can only acquire spacers through naı¨ve
acquisition, although this acquisition is very rare and un-
likely to be observed over the timespan of our experiment
(28). Interestingly, we observe spacer acquisition for both
bona fide target plasmids in the hns strain (10–25% of
colonies tested) (Figure 1F) but no spacer acquisition in
the hnscse1 strain (not shown). These data indicate that
spacers were acquired through priming against the bona
fide targets in the hns strain, and not through naı¨ve ac-
quisition. It is possible that the plasmid may develop es-
cape mutations over the course of the experiment, and that
these mutant targets could lead to the observed priming.
However, we observe reproducible variability in the amount
of priming for the two targets (Figure 1F), indicating that
priming is not caused by random mutations but is instead
directed from the bona fide targets. Together with our seed
mutation experiments, these results reveal that targets that
can undergo direct interference can also promote priming.
High-throughput screen for PAM and seed mutation toler-
ance
We next wanted to establish a high-throughput system to
study spacer sequence-specific tolerance of seed or PAM
mutations by the CRISPR interference machinery. In order
to study a large number of mutant sequences, we developed
a high-throughput method to detect CRISPR-dependent
loss of a plasmid expressing green fluorescence protein
(GFP) using flow cytometry (Supplementary Figure S3).
Based on this system, we created a novel high-throughput
screening method to determine the effects of both seed and
PAMmutations on priming and direct interference for mul-
tiple spacer sequences (Figure 2A–C). Our screen utilizes
two E. coli strains, X019 cas1 and X019, to distinguish
between targets that can be lost through direct interfer-
ence and targets that can be lost through both direct in-
terference and priming, respectively. In comparison to the
control strain X019 cse1, libraries of PAM and seed mu-
tants grown in X019cas1 and X019 will be depleted of se-
quences that are functional, while non-functional sequences
may be unchanged or enriched.
Target libraries for spacer 1.1 and 2.1 were created by ran-
domizing the PAM or the seed (Figure 2A). A completely
degenerate library was created for the PAM (64 possible se-
quences). To ensure complete coverage of seed mutations
(16,384 possible sequences), we created a limited degener-
ate library in which positions 1–5, 7–8 of the protospacer
had two possible sequences, either the correct sequence or a
mismatch, resulting in 128 possible sequences (Figure 2A).
For all libraries, we performed a first round selection pro-
cess by transforming and growing the libraries in the control
X019 cse1 strain, and the two experimental strains, X019
cas1 and X019 (Figure 2B). Following this selection pro-
cess, libraries were extracted from each strain and were then
subjected to a second round of CRISPR interference in E.
coli X019, to verify the success of the first round selection
(Figure 2C).
For both plasmid loss and spacer acquisition (Figure 2D-
E), there is no difference between the original libraries and
libraries extracted from X019 cse1, which indicates that
plasmid distribution did not change through non-CRISPR-
related mechanisms and any changes in the X019 and X019
cas1 libraries resulted from the CRISPR–Cas immune
system. Interestingly, differences in the rate of plasmid loss
between the X019 cas1 and X019 libraries are larger for
the PAM mutant libraries than the seed mutant libraries
(Figure 2D), suggesting that there are several PAM muta-
tions that can block interference but still enable priming,
while seed mutations that promote priming are more likely
to also be tolerated for direct interference.
As expected, GFP- cells grown with the X019 cas1 li-
braries exhibited high rates of spacer acquisition, similar to
those observed for the original DH5 and X019 cse1 li-
braries that contain all functional sequences (Figure 2E).
This indicates that the X019 cas1 libraries still contain
sequences that can promote priming. In contrast, GFP-
cells from the X019 library had very low rates of spacer
acquisition (Figure 2E), indicating that the majority of se-
quences that promote priming were lost during the first
round of growth. Therefore, comparison of sequences de-
pleted from the X019 cse1 and X019 libraries should dis-
tinguish which sequences can be lost through direct inter-
ference and which can only be lost through priming.
High-throughput sequencing of libraries
We next sequenced PCR amiplicons of the PAM–
protospacer region for each library using MiSeq Illumina
sequencing (Figure 2A-B). To determine the relative de-
pletion or enrichment of sequences in each library, counts
from the X019 cse1, X019 cas1 and X019 libraries
were normalized to the original DH5 library (Figures 3
and 4, Supplementary Figures S4 and S6). As expected
based on our second round analysis of the libraries, the
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Figure 2. High-throughput screen for CRISPR activity of PAM and seed mutants. (A–C) Experimental design for high-throughput screen. (A) PAM and
seed library construction. PAM libraries contained completely degenerate sequences at the -3, -2 and -1 positions of the target, resulting in 64 possible
sequences. Seed libraries contained two potential sequences at each positions 1–5 and 7–8 of the target, resulting in 128 possible sequences. (B) The original
libraries were transformed to E. coli X019, X019 cas1 and X019 cse1 and libraries were prepared for each strain after an extended growth period in
non-selective media. These libraries were used for barcoded PCR as experimental samples for high-throughput sequencing analysis. (C) All libraries were
transformed to E. coli X019 and grown for 2 cycles of 6–12 h. Cells were sorted by FACS to measure rates of plasmid loss and the genomic DNA of
GFP- cells were used for PCR of CRISPRs to determine rates of spacer acquisition. (D) Plasmid loss rates for libraries created using this high-throughput
experimental design, as measured by percent of GFP- cells for ∼100 000 cells tested. (E) Spacer acquisition rates for the libraries.
original DH5 library and X019 cse1 libraries are highly
similar, while both the X019 cas1 and X019 libraries
have many sequences that are highly depleted. In addition,
the X019 cas1 and X019 libraries have many sequences
that are enriched relative to the original libraries, as is
expected given the depletion of several sequences. Several
highly enriched sequences were also observed, especially
for the seed mutant libraries. This enrichment appears to
be sequence specific, as it occurred consistently across three
biological replicates (Supplementary Figures S4 and S6).
These sequences may have had a higher transformation
efficiency in the X019 or X019 cas1 strains, or they may
have been relatively stabilized in one of the strains during
growth.
For spacer 2.1 we created an additional seed library con-
taining a mismatch at position 6 of the protospacer (here-
after called spacer 2.1 6MM) (Supplementary Figure S4A,
D, G, J). This position has been shown previously to have
no effect on interference, as the crRNA of Cascade does not
base pair with every sixth nucleotide of the protospacer tar-
get strand (23,36). Consistently, this library has similar de-
pletion profiles to the seed library with the correct sequence
at position 6 (Figure 3C, Supplementary Figure S4A). Dif-
ferences between the two libraries may be due to variations
in the timing of growth cycles for the two libraries. The over-
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Figure 3. One or two mismatches in the seed can be tolerated for CRISPR activity. (A) Seed libraries tested in this study. The crRNA seed sequence and
corresponding region of the non-target strand of the protospacer are shown. Degenerate DNA labels: Y – cytosine or thymine; R – adenine or guanine; S
– guanine or cytosine. (B and C) Counts of sequences with one or two mismatches in the seed sequence for X019 cse1, X019 cas1, and X019 relative to
the reference DH5 library. (B) Spacer 1.1 seed libraries. (C) Spacer 2.1 seed libraries. Mismatch position(s) are labeled for each set of data.
all similarity between the datasets indicates that the high-
throughput method presented here is largely reproducible.
One or two seed mutations allow CRISPR activity
Analysis of seed sequence depletion for the spacer 1.1 and
2.1 libraries reveals that almost all sequences with one or
two mismatches are functional (Figure 3, Supplementary
Figure S4A), while three or more mismatches in the seed
render the CRISPR immune system nearly completely in-
active (Supplementary Figure S4B–J). As predicted based
on the second round growth experiments with the seed mu-
tant libraries (Figure 2D andE), several functional seedmu-
tant sequences are highly depleted in both the X019 and
X019 cas1 strain, indicating that many seed mismatches
that promote priming do not completely block direct in-
terference. For both spacers, a single seed mutation does
not block interference, with two exceptions: position 1 for
spacer 1.1, as observed in our initial experiments (Figures
1A and 3B); and position 4 for spacer 2.1, which we con-
firmed in an individual assay (Figure 3C, Supplementary
Figures S4A, S5). These defects are compounded by the
addition of another seed mismatch, as very little depletion
is observed in either X019 or X019 cas1 libraries for se-
quences with two mismatches where one of the mismatches
is at position 1 for spacer 1.1 or at position 4 for spacer 2.1
(Figure 3B and C, Supplementary Figure S4A). Combined
with our in vitro studies of spacer 1.1 (Figure 1E, Supple-
mentary Figure S2A), this result implies that single seed
mismatches that inhibit direct interference reduce the affin-
ity of Cascade for the target, and that a second mismatch in
the seed blocks Cascade binding completely, such that even
priming is not observed.
In contrast, combinations of seed mutations that do not
block interference individually generally allow some degree
of direct interference and often promote efficient priming,
based on abundance of these sequences in X019 cas1 and
X019, respectively (Figure 3B and C). Notably, the spacer
1.1 target with mutations at positions 5 and 7 is highly de-
pleted in both strains, but the spacer 2.1 target with mis-
matches at the same positions is stable in both strains (Fig-
ure 3B-C). Similarly, the targets with mutations at positions
2 and 8 are depleted from the spacer 2.1 libraries but not the
spacer 1.1 libraries (Figure 3B and C). These data suggest
that up to two seed mismatches can be tolerated for direct
interference, and provide further evidence that the determi-
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Figure 4. Direct interference and priming can be promoted by a large
set of PAM sequences. (A and B) Scatter plots for relative counts of 64
PAM/Protospacer sequence for libraries extracted from E. coli X019 ver-
sus E. coliX019cas1 for (A) spacer 1.1 targets and (B) spacer 2.1 targets.
Counts are relative to the E. coli DH5 reference library. (C and D) PAM
sequences colored by groups as defined in (A and B) for (C) spacer 1.1
targets and (D) spacer 2.1 targets. Red: Group A, blue: Group B, purple:
Group C, black: Group D. (E) Plasmid loss and spacer acquisition rates
for spacer 1.1 and 2.1 targets with AAA, AAC, ATA or AGA PAMs after
24 h growth.
nants for position-specific mismatch tolerance is dependent
on spacer sequence.
PAM tolerance is highly dependent on spacer sequence
For the PAM libraries, the counts for X019cas1 andX019
relative to DH5 were plotted as a scatter plot, allowing
for direct comparison of sequences that promote both di-
rect interference and priming (X019) versus sequences that
only promote direct interference (X109 cas1) (Figure 4A
and B). Based on their relative amount of CRISPR activity,
PAMs were divided into four groups (Figure 4A-D). Group
A contains bona fide PAM sequences that are highly de-
pleted in both strains. Group B contains PAMs that do not
fully block direct interference, resulting in some depletion
in X019 cas1 (<0.9 relative to DH5 reference library),
but not as significantly as for X019. Group C contains se-
quences that block direct interference but promote priming,
resulting in depletion in X019 but no change in X019cas1
(>0.9 relative to DH5 reference library). Group D con-
tains sequences that are stable in both strains (>0.9 rela-
tive to DH5 reference library). Notably, sequences within
groups A-C prefer adenine residues at the -3 and -2 posi-
tions and a guanine residue at the -1 position (Figure 4C
and D). In contrast, PAMs with cytosine residues at posi-
tions -3 or -2 are highly represented in group D, indicating
that a C at either position disrupts CRISPR–Cas activity
(Figure 4C and D).
In both libraries, group A contains five previously iden-
tified PAMs that can promote interference (AAG, AGG,
ATG, GAG and TAG) located near the origin of the plot,
indicating that targets with these PAM sequences are lost
in both strains through direct interference as expected (Fig-
ure 4A-D and Supplementary Figure S6) (26,36). Surpris-
ingly, for spacer 1.1, there are three additional PAM se-
quences (AAA, AAC and ATA) located near the origin of
the plot, suggesting that spacer 1.1 can tolerate eight dif-
ferent PAM sequences for interference (Figure 4A, C and
Supplementary Figure S6A). In individual assays, all three
spacer 1.1 targets can be lost through direct interference in
X019cas1 (Figure 4E), and theAAAPAM target displays
the accompanying low rate of spacer acquisition observed
for bona fide targets (Figures 1F and 4E). Strikingly, for
spacer 2.1, the AAA and ATA targets are relatively stable
in X019 cas1 but promote high efficiency priming (Fig-
ure 4E), suggesting that, in contrast to spacer 1.1, direct in-
terference is strongly inhibited for these targets. Thus, sim-
ilar to seed mutations, spacer sequence appears to dictate
whether mutant PAM sequences can be tolerated for direct
interference or mainly promote priming.
We additionally observed several PAMsequences that are
functional for one spacer but have no activity for the other
spacer. For example, severalGroupCPAMs (ATTandTAC
for spacer 1.1, AGA, AGC and CTG for spacer 2.1) are
nonfunctional for the other spacer (Figure 4A–D, Supple-
mentary Figure S6). To validate this observation, we cre-
ated target plasmids for both spacers containing an AGA
PAM and tested their CRISPR activity in individual assays
(Figure 4E). Consistent with the high-throughput experi-
ment, we observe no CRISPR activity against the spacer
1.1 target containing an AGA PAM (Figure 4E). In con-
trast, spacer 2.1 can promote efficient priming against tar-
gets containing an AGA PAM, although direct interference
in X019 cas1 is completely blocked (Figure 4E). These
data demonstrate that some potentially functional PAM se-
quences can be rendered completely nonfunctional based
on the spacer sequence, andmay explain differences in func-
tional PAMs identified by high-throughput screens in ours
and previous studies (36).
A self-signal protects the host genome from autopriming
Our high-throughput results indicate that cytosine residues
at the -3 and -2 positions of the PAM inhibit both interfer-
ence and priming (Figure 4C and D). In the E. coli genome,
the final three nucleotides of the repeat are CCG, suggest-
ing that the repeat sequence may encode an inactive ‘PAM’
sequence to prevent Cascade binding to the spacer tem-
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Figure 5. Repeat nucleotides at the PAM (i.e. CCG at position -3, -2, -1) protect the CRISPR array from priming. The sequence of the distal repeat is
shown in truncated form in the upper two sequences. The sequence of the spacer is shaded in gray in the top sequence. Red sequences indicate mutated
nucleotides.
plate strand. To investigate if repeat-derived nucleotides at
PAM positions indeed protect the CRISPR array from sui-
cidal autopriming, we constructed a CRISPR-like target
plasmid containing a non-transcribed repeat – spacer – re-
peat sequence (Figure 5). This plasmid was introduced in
E. coli cells that contained the same spacer in the genome,
and checked for stable maintenance and priming in non-
selective media. As expected, the CRISPR-like target plas-
mid showed no priming. However, when we deleted the
proximal repeat of the target plasmid, we regained prim-
ing behavior of the plasmid (Figure 5). We then constructed
a series of proximal CRISPR repeat variants, including
blocks of mutations and truncations from the 5′ end of the
repeat. Assessing their priming behavior revealed that only
when repeat nucleotides at positions -3 to -1 (i.e. CCG) were
altered, the plasmid was subject to priming. This means
that the presence of repeat nucleotides directly adjacent to
the spacer protects CRISPR arrays from self-priming and
therefore from autoimmunity.
Differential interference against AGA PAM targets based on
spacer sequence
Our results indicate that spacer sequence can greatly influ-
ence the activity of the interference machinery against tar-
gets with altered PAM or seed sequences. For example, our
observation that an AGAPAM completely blocks CRISPR
activity against spacer 1.1 targets suggests that Cascade
binding is blocked, while spacer 2.1 AGA PAM targets may
still be bound by Cascade to promote priming, but not de-
graded by Cas3 to block interference (Figure 4E). To test
this, we purified Cascade with crRNAs bearing spacer 1.1
or spacer 2.1, and tested binding of their respective targets
containing AGA PAMs using electrophoretic mobility shift
assays (EMSA) (Figure 6A–B). Spacer 2.1 Cascade can still
bind the AGA PAM target and there is little difference be-
tween the affinities for the AGA PAM target and the AAG
PAMtarget (Figure 6B). In contrast, for spacer 1.1Cascade,
AGAPAM target binding is only observed at very high con-
centrations of Cascade (1–2 M), and is likely due to non-
specific DNA binding that is often observed at high con-
centrations of Cascade (Figure 6A) (21,26,30). These data
reveal that spacer sequence can have a major impact on the
ability of Cascade to bind targets with incorrect PAM se-
quences.
After confirming that Cascade can bind a spacer 2.1 tar-
get with an AGA PAM, we next investigated whether Cas3
can degrade this Cascade-bound target in vitro. Strikingly,
the spacer 2.1 AGA PAM target is not cleaved at any con-
centration of Cas3, even up to 2 M (Figure 6C). These
results are consistent with the complete lack of direct inter-
ference observed in vivo against the AGA PAM target (Fig-
ure 4E). Overall, these in vitro results for a priming PAMare
in sharp contrast to the seed mutant targets we have tested,
in particular the spacer 1.1 position 1 mutant target, which,
similar to the spacer 2.1 AGA PAM target, promotes prim-
ing but strongly inhibits direct interference (Figures 1C and
4E). For the PAM mutant target, Cascade binding affinity
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Figure 6. Priming PAM blocks Cascade-mediated Cas3 cleavage but not Cas3-Cascade association. (A and B) Electrophoretic mobility shift assay for
Cascade binding to (A) spacer 1.1 and (B) 2.1 targets with AAG or AGA PAMs. Cse2–Cas6e concentration is varied, and concentrations are labeled for
each sample. Cse1 concentration was held constant at 1 M to ensure complete formation of the Cascade complex. (C) Cascade-mediated Cas3 cleavage of
spacer 2.1 targets with AAG or AGA PAMs. Plasmid DNA is labeled as follows: OC – open circle; L – linear; nSC – negatively supercoiled; D – degraded.
(D–F) Confocal micrographs for BiFC experiments detecting interactions between Cse1 and Cas3. (D) E. coli BW25113 cse1Δcas3 grown with pACYC-
BiFC and empty pCDF-1b plasmid. (E) E. coli BW25113 cse1Δcas3 grown with pACYC-BiFC and pCDF containing spacer 2.1 target with an AAG
PAM. (F) E. coli BW25113 cse1Δcas3 grown with pACYC-BiFC and pCDF containing spacer 2.1 target with an AGA PAM.
is not greatly affected, but Cascade-mediated Cas3 cleavage
is completely blocked (Figure 6B and C). For the seed mu-
tant target, inhibition of interference appears to be caused
by a defect in Cascade binding, but Cas3 cleavage appears
to be unaffected for Cascade-bound target (Figure 1E, Sup-
plementary Figure S2A).
Cas3 can be recruited to, but does not cleave, a priming PAM
target in vivo
We next wanted to determine whether the lack of Cascade-
mediated degradation for the spacer 2.1 AGA target occurs
because Cas3 cannot be recruited to Cascade bound to this
target, or instead because Cas3 can be recruited but cannot
initiate degradation. To investigate this, we used bimolec-
ular fluorescence complementation (BiFC) experiments to
monitor the interaction between Cascade and Cas3 in vivo
(Figure 6D–F). Previously, BiFChas been used to show that
Cascade cannot interact with Cas3 in the absence of an in-
vading DNA sequence containing a correct PAM and pro-
tospacer (26). Cas3 was only recruited to Cascade by the
Cse1 subunit in the presence of a target DNA. We used a
similar experimental design, in whichwe fusedCse1 withN-
terminal Venus and Cas3 with C-terminal Venus in a single
expression vector (pACYC-BiFC). Each fragment of Venus
is non-fluorescent, but fluorescence is reconstituted upon
interaction between Cas3 and Cse1, which brings the two
Venus fragments into proximity.
For BiFC experiments, we co-transformed pACYC-BiFC
with various target plasmids in E. coli X030 (hns, cse1 and
cas3 genes deleted). E. coli containing a non-target plasmid
(empty pCDF-1b) were non-fluorescent, indicating that a
target plasmid is necessary for Cas3 and Cse1 interaction
 at Iow
a State U
niversity on M
ay 12, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015, Vol. 43, No. 22 10843
Figure 7. Naı¨ve adaptation triggers a rapid priming response. (A) Anal-
ysis of PAM sequences for spacers acquired in Yosef et al. naı¨ve adapta-
tion study (29). In the study, spacers were acquired from the E. coli ge-
nomic DNA or a plasmid borne by host. Percentage of reads for spacers
derived from sequences with AAG PAMs or other functional or nonfunc-
tional PAMs identified in our study are plotted. Total distribution of each
type of PAM in each source DNA are also plotted. (B) Quantified PCR
product resulting from newly acquired spacer from three adaptation sce-
narios following two cycles of growth. Scenario 3 products with significant
differences (P < 0.005 based on unpaired two-tailed t-test, n = 3 cultures)
compared to scenario 1 are marked with an asterisk. (C and D) Model for
adaptation during initial encounter of invaderDNA.Naı¨ve adaptation, re-
quiring only the adaptation machinery (orange), allows for integration of
spacers against the previously unencountered virus. Spacersmay be against
targets with PAMs that promote (C) interference or (D) priming by the in-
terference machinery (blue). Cascade bearing newly acquired spacers can
bind targets with (C) interference or (D) priming PAMs and recruit Cas3.
PAM licensing at this step elicits a (C) target degradation or (D) priming
response, although rare occurrences of the alternative mechanism are also
possible for each type of target.
(Figure 6D). As expected, fluorescent signal is observable in
E. coli carrying the bona fide target plasmid, indicating that
Cascade has bound to the target and recruited Cas3 (Figure
6E). Interestingly, the AGA target plasmid also induces flu-
orescence at similar levels to those observed with the AAG
target (Figure 6F). These results indicate that Cas3 can still
be recruited to the Cascade-AGA target complex, but in a
manner that does not lead to target degradation.
Naı¨ve spacer acquisition leads to rapid primed adaptation
During naı¨ve adaptation, spacers are acquired at a rela-
tively low rate, and many spacers are acquired from pro-
tospacer locations containing PAMs that differ from the
canonical AAG sequence (11,12,29,56,57). We wondered
whether functional PAMs are enriched for sequences ac-
quired through naı¨ve acquisition. We compared PAM se-
quences from a previously published set of spacers acquired
through naı¨ve adaptation with functional PAMs identi-
fied in this study (Figure 7A and Supplementary Figure
S7A) (29). In the previous study, spacers could be acquired
against both the genomic DNA and a Cas1–Cas2 expres-
sion plasmid. Although functional PAMs are∼1.8-fold less
abundant than nonfunctional PAMs in both source DNAs,
spacers derived from sequences with functional PAMs are
acquired ∼2.5-fold more frequently (Figure 7A). Interest-
ingly, functional PAMs are nearly equally divided between
AAG and non-AAG sequences among the acquired spac-
ers. We also note that some PAM sequences, especially
the highly enriched ACG, have been identified in another
study as priming PAMs, but were not identified in our high-
throughput study potentially due to differences in spacer se-
quences used in the two studies (36).
Given the high proportion of functional PAMs observed
in the previous data set, we hypothesized that naı¨ve acqui-
sition should rapidly trigger a primed adaptation response
to previously unencountered invader DNA. To test this hy-
pothesis, we simulated three adaptation scenarios: (i) inva-
sion by a previously unencountered DNA (empty plasmid)
with only naı¨ve adaptation (cse1 deletion strain); (ii) inva-
sion by a previously encountered DNA (spacer 2.1 AGA
target plasmid) with a primed adaptation response; (iii) in-
vasion by a previously unencounteredDNAwith both naı¨ve
and primed adaptation responses (Figure 7B, Supplemen-
tary Figure S7B). In all three scenarios, we increased the rate
of naı¨ve acquisition through constitutive overexpression of
Cas1 and Cas2 using an expression plasmid (29).
As expected, naı¨ve adaptation is significantly slower than
priming, based on the number and amount of spacers ac-
quired in the scenario 1 versus scenario 2 cultures, respec-
tively (Figure 7B and Supplementary Figure S7B). Scenario
3 mimics an actual naı¨ve infection event, in which both
adaptation and interference activities are functional. Ini-
tially, the only CRISPR–Cas response against the previ-
ously unencounteredDNA is naı¨ve adaptation, and accord-
ingly spacer acquisition after one cycle of growth is very low
(Supplementary Figure S7B). The slow naı¨ve response ob-
served in the scenario 1 culture is exacerbated in the sce-
nario 3 culture, as spacers acquired against the genomic
DNA or Cas1–Cas2 expression plasmid are not permitted
when the interference machinery is intact. However, over
time, adaptation in the scenario 3 culture overtakes the rate
of the scenario 1 culture, based on the amount of spacer ac-
quisition observed after a second cycle of growth (Figure
7B and Supplementary Figure S7B). When priming is ac-
tive, bacteria can acquire multiple spacers more rapidly, as
evidenced by the statistically significant increase in product
for 2 and 3 acquired spacers in the scenario 3 analysis versus
scenario 1 (Figure 7B). Together, these results suggest that
preferential uptake of spacers against targets with any type
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of functional PAM during naı¨ve adaptation may lead to a
rapid priming response to infection.
DISCUSSION
In this study, we have reexamined the sequence require-
ments for CRISPR interference and primed spacer acqui-
sition in the Type I-E CRISPR–Cas immune system. Our
results reveal that single point mutations within the seed
sequence of target protospacers do not completely block
CRISPR interference, and in some cases are highly toler-
ated. Similarly, some non-canonical PAM sequences can be
tolerated for direct interference, especially those with ade-
nine residues at the -3 or -2 position or a guanine residue at
the -1 position. Suprisingly, the crRNA spacer sequence has
a significant effect on the ability of the interference machin-
ery to recognize protospacers with seed mutations or non-
canonical PAM sequences. Intriguingly, this result suggests
that spacers that are highly tolerant of mutations through-
out the seed may be more effective for CRISPR–Cas im-
munity, as they may provide a broader range of immunity
against potential escape mutants or related invaders. In the
future, it will be interesting to evaluate whether bacteria
preferentially incorporate spacers with higher tolerance of
mutated seed or PAM sequences. At present, the determi-
nants for these spacer sequence-specific effects are unclear
and amore systematic study of spacer/target sequence vari-
ations will be necessary to decipher the code for mutational
tolerance by CRISPR–Cas systems.
Our results differ from previous studies, which have
shown that single point mutations in the protospacer seed
or PAM sequences block the CRISPR interference pathway
(31,36,58). In many cases, these mutations lead to primed
spacer acquisition (11,28), making it difficult to deconvo-
lute indirect interference driven by newly acquired spacers
from direct interference driven by the original spacer. By
using a cas1 deletion strain, we decoupled direct interfer-
ence from priming, definitively demonstrating the extent to
which seed and PAM mutations can be tolerated for inter-
ference. In addition, differences between ours and previous
studies may be due to variations in experimental design be-
tween studies. For example, phage-infectivity and plasmid-
based assays have previously been observed to yield dif-
fering results when assessing CRISPR interference (58,59).
Seed or PAMmutations that are tolerated in plasmid-based
assaysmay sufficiently blockCRISPR interference allowing
for phage escape at high multiplicities of infection, includ-
ing conditions found in the environment. Going forward, it
will be important to assess how mutational tolerance may
vary based on the outcome of invasion by different types of
mobile genetic elements.
Self-sequence avoidance in the Type I-E system
To prevent autoimmunity, CRISPR–Cas immune systems
must distinguish non-self protospacer sequences from iden-
tical self-spacer sequences present in the CRISPR array.
Type III-A systems accomplish this self vs. non-self recog-
nition based on differential complementarity between the
crRNA and sequences flanking the target (60). Types I and
II CRISPR–Cas immune systems utilize PAM sequences
to differentiate targets from non-targets (17,30,58), but a
mechanism for avoidance of self sequences has not been
previously identified. Our high-throughput PAM mutant
screen revealed that cytosine residues at the -3 and -2 po-
sition of the PAM prevents both interference and priming.
Consistent with this observation, we found that the final 3
nucleotides of the preceding repeat (CCG) prevent priming
against a spacer in the context of a CRISPR array. The po-
sition of this 3-nucleotide protective element is identical to
where PAMs reside in target DNA and indicates that PAM
recognition is actually more sophisticated than previously
thought (30,58). Apart from authenticating bona fide tar-
gets for direct interference, many PAM sequences are eligi-
ble for priming (34,56, this work). The repeat-PAM, how-
ever, abolishes both pathways by providing a genuine self-
signal, and this leaves the CRISPR array exempt from detri-
mental autopriming.
Mechanistic insights into CRISPR–Cas immunity
Overall, the large number of functional PAMs identified in
our study, including several noncanonical PAMs that allow
some degree of direct interference, suggests that Cascade-
target binding requirements are less stringent than previ-
ously thought. We found that Cascade binding affinity for
targets with noncanonical PAMs is significantly affected by
the spacer sequence, and that some targets with priming
PAMs can be boundwith high affinity.WhenCascade binds
priming PAM targets, Cas3 is recruited but does not cleave
the DNA. Similarly, a recent single-molecule study of the
Streptococcus thermophilus Type I-E Cascade found that
low-affinity, non-permissive PAM targets with induced R-
loops were cleaved at a very low rate by Cas3 (34), and bulk
biochemical studies have indicated that targets with mu-
tated PAM sequences cannot be cleaved by Cas3 (25,27,37).
Notably, for high-affinity priming PAM targets, PAM dis-
crimination apparently occurs following target binding, but
prior to target cleavage. Thus, targets with noncanonical
PAMs may be bound with high affinity by Cascade, but a
second PAMauthentication step prevents interference from
occurring.
The molecular basis for PAM authentication during tar-
get cleavage is currently unknown. It is possible that inter-
actions between Cascade or Cas3 and the PAM sequence
may differ for interference and priming PAMs, resulting in
alternative conformations that lead to the two different im-
mune reactions. This idea is consistent with recent single-
molecule FRET studies of Cascade-target binding, which
revealed that Cascade engages priming targets in a non-
canonical binding mode (37). However, the mode of bind-
ing observed in that study was relatively short-lived, and it
is unclear whether the high-affinity Cascade-target interac-
tion we observe for the spacer 2.1 AGA target is analogous
to this binding event. Our identification of a high-affinity
priming PAM target should enable further study into the
conformations that promote priming and the mechanism of
PAM authentication during target cleavage.
The mechanisms of interference and priming appear to
exist in a dynamic equilibrium in which targets that block
interference promote priming, and targets that allow inter-
ference inhibit priming. In general, target sequences that are
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tolerated for direct interference lead to inefficient priming,
including bona fide targets and several of the seed and PAM
mutants tested in our study. It is possible that this ineffi-
ciency is caused by loss of the target plasmid through rapid
target degradation through CRISPR interference, thus lim-
iting the amount of invader DNA from which to acquire
new spacers. In this case, the equilibrium between interfer-
ence and priming favors interference and disfavors prim-
ing, whereas mutations that block interference push the
equilibrium toward priming. Consistently, the short-lived
noncanonical binding mode observed by single-molecule
FRET for priming targets was also observed for bona fide
targets (37), suggesting that Cascade can sample an alter-
native binding mode that promotes priming for any type
of target. The noncanonical binding mode may occur rel-
atively rarely for high-affinity targets that can adopt the in-
terference binding mode, including bona fide targets and
targets with seed or PAM mutations that are tolerated for
direct interference.
Priming is a major mechanism for adaptation
Primed spacer acquisition allows bacteria to mount a rapid
defense against infection, even in the presence of PAM or
protospacer mutations that could allow an invader DNA
to escape CRISPR interference. In addition, the promiscu-
ity of Cascade in recognizing priming PAMs may have im-
plications during the early stages of CRISPR–Cas adapta-
tion. We showed that naı¨ve acquisition can lead to a rapid
priming response, suggesting that previously identified ‘in-
correct’ PAMs of sequences acquired during naı¨ve adapta-
tion are likely actually functional PAMs that promote prim-
ing (11,12,29,56,57). These data suggest that the Cas1–Cas2
acquisition complex, like Cascade, may recognize a broad
range of PAM sequences that can promote either interfer-
ence or priming in the absence of Cascade and Cas3. No-
tably, different adaptation specificities have been observed
for the E. coli K12 and O157:H7 Type I-E variants, which
preferentially acquire protospacers with AAG and ATG
PAMs, respectively (57). These observations suggest that
the closely related Cas1-Cas2 homologs (85% identity) in
these Type I-E variants bind alternative functional PAMs
with variable affinities, resulting in different PAM prefer-
ences. A recent crystal structure of the E. coli K12 Cas1-
Cas2 complex bound to a PAM-containing protospacer re-
veals the structural basis for preferential AAG PAM recog-
nition, and will be important for guiding future studies of
functional PAM selectivity (62).
Together with previous results, our findings suggest that
naı¨ve adaptation is a mechanism for acquiring spacers for
both interference and priming, while primed adaptation is a
mechanism for acquiring only interference spacers (11,56).
This two-tiered strategymay be of particular importance for
adaptation against invaders with depleted canonical PAM
sequences, as has been observed for several bacteriophages
with hosts containing CRISPR–Cas systems (63). During
initial infection, a naı¨ve adaptation strategy in which only
protospacers with canonical PAM sequences were acquired
would severely limit the ability of the host to mount an
effective defense. Instead, the CRISPR–Cas system over-
comes this limitation by initially acquiring any sequence ad-
jacent to a functional PAM during naı¨ve adaptation, then
honing the system for interference through priming. Prim-
ing may, in fact, be the major mechanism for adaptation in
Type I systems. In the Haloarcula hispanica Type I-B sys-
tem, priming is strictly required for adaptation and naı¨ve
adaptation has not been observed (64). Similar to our ob-
servations, this system has relaxed stringency for priming
PAM sequences, maximizing the adaptation capacity dur-
ing an invasion event (61). ThePectobacterium atrosepticum
Type I-F system contains a Cas2-Cas3 fusion, physically
linking the naı¨ve and primed acquisition machinery and re-
sulting in extremely robust priming in this organism (65). It
is possible that the Type I-E system also uses priming as the
main mechanism for adaptation, and that naı¨ve acquisition
is simply a means to enable priming.
Model for priming and interference dynamics in E. coli
Overall, our results suggest a model for adaptation during
the initial encounter of an invader DNA (Figure 7C andD).
The Cas1-Cas2 complex initially acquires new spacers from
any region of a replicating invader (66), preferentially incor-
porating sequences that are adjacent to functional PAMs.
Cascade bearing the resulting crRNAs can bind to these tar-
gets and recruit Cas3. Prior to target degradation, the PAM
is authenticated through an unknown mechanism, and this
leads to either interference (Figure 7C) or priming (Fig-
ure 7D). Depending on the PAM sequence, the frequency
of these two responses will vary, with bona fide PAM tar-
gets leading to a majority of interference and few prim-
ing events (Figure 7C) and priming PAM targets leading to
rapid spacer acquisition and infrequent interference events
(Figure 7D). Thus, the initial spacers acquired during naı¨ve
acquisition allow the CRISPR–Cas system to simultane-
ously mount two defensive responses to infection.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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